Rationalizing the Use of Functionalized Poly-Lactic-Co-Glycolic Acid Nanoparticles for Dendritic Cell-Based Targeted Anticancer Therapy

References

• Conniot J Silva JM Fernandes JG et al. Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking. Front. Chem.2, 105 (2014).
   PubMed Web of Science ®Google Scholar
• Cruz LJ Tacken PJ Rueda F Carles Domingo J Albericio F Figdor CG . Targeting nanoparticles to dendritic cells for immunotherapy. Meth. Enzymol.509, 143 – 146 (2012).
   PubMed Web of Science ®Google Scholar
• Savla R Ivanova V Minko T . Nanoparticles in the development of therapeutic cancer vaccines. Pharm. Nanotechnol.2 (1), 2 – 22 (2014).
   Google Scholar
• Müller L McArdle S Derhovanessian E et al. Current strategies for the identification of immunogenic epitopes of tumor antigens. In : Immunotherapy of Cancer. Humana Press, NY, USA, 21 – 44 (2006).
   Google Scholar
• Akagi T Baba M Akashi M . Biodegradable nanoparticles as vaccine adjuvants and delivery systems: regulation of immune responses by nanoparticle-based vaccine. In : Polymers in Nanomedicine. Springer-Verlag, Berlin, Heidelberg, 31 – 64 (2012).
   Google Scholar
• Krishnamachari Y . PLGA microparticle based vaccine carriers for an improved and efficacious tumor therapy. Chapter 1, 1–16 (2011). http://ir.uiowa.edu/etd/2922/.
   Google Scholar
• Krishnamachari Y Geary SM Lemke CD Salem AK . Nanoparticle delivery systems in cancer vaccines. Pharm. Res.28 (2), 215 – 236 (2011).
   PubMed Web of Science ®Google Scholar
• Krishnamachari Y Salem AK . Innovative strategies for co-delivering antigens and CpG oligonucleotides. Adv. Drug Deliv. Rev.61 (3), 205 – 217 (2009).
   PubMed Web of Science ®Google Scholar
• Kokate RA Thamake SI Chaudhary P et al. Enhancement of anti-tumor effect of particulate vaccine delivery system by'bacteriomimetic'CpG functionalization of poly-lactic-co-glycolic acid nanoparticles. Nanomedicine10 (6), 915 – 929 (2015).
   PubMed Web of Science ®Google Scholar
• Cruz LJ Tacken PJ Fokkink R et al. Targeted PLGA nano-but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro. J. Control. Release144 (2), 118 – 126 (2010).
   PubMed Web of Science ®Google Scholar
• Klippstein R Pozo D . Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies. Nanomedicine6 (4), 523 – 529 (2010).
   PubMed Web of Science ®Google Scholar
• Palucka K Banchereau J . Cancer immunotherapy via dendritic cells. Nat. Rev. Cancer12 (4), 265 – 277 (2012).
   PubMed Web of Science ®Google Scholar
• Palucka K Banchereau J Mellman I . Designing vaccines based on biology of human dendritic cell subsets. Immunity33 (4), 464 – 478 (2010).
   PubMed Web of Science ®Google Scholar
• Palucka K Ueno H Zurawski G Fay J Banchereau J . Building on dendritic cell subsets to improve cancer vaccines. Curr. Opin. Immunol.22 (2), 258 – 263 (2010).
   PubMed Web of Science ®Google Scholar
• Hamdy S Haddadi A Hung RW Lavasanifar A . Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations. Adv. Drug Deliv. Rev.63 (10), 943 – 955 (2011).
   PubMed Web of Science ®Google Scholar
• Manish M Rahi A Kaur M Bhatnagar R Singh S . A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge. PLoS ONE8 (4), e61885 (2013).
   PubMed Web of Science ®Google Scholar
• Kim B Jones HP . Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-γ by CD4+ T cells. Brain Behav. Immun.24 (7), 1126 – 1136 (2010).
   PubMed Web of Science ®Google Scholar
• Feldman JP Goldwasser R Mark S Schwartz J Orion I . A mathematical model for tumor volume evaluation using two-dimensions. J. Appl. Quant. Methods4, 455 – 462 (2009).
   Google Scholar
• Drabkin DL Austin JH . Spectrophotometric studies II. Preparations from washed blood cells; nitric oxide hemoglobin and sulfhemoglobin. J. Biol. Chem.112 (1), 51 – 65 (1935).
   Google Scholar
• Sheng K Pietersz GA Wright MD Apostolopoulos V . Dendritic cells: activation and maturation-applications for cancer immunotherapy. Curr. Med. Chem.12 (15), 1783 – 1800 (2005).
   PubMed Web of Science ®Google Scholar
• Prabhu RH Patravale VB Joshi MD . Polymeric nanoparticles for targeted treatment in oncology: current insights. Int. J. Nanomedicine10, 1001 (2015).
   PubMed Web of Science ®Google Scholar
• Rosalia RA Cruz LJ van Duikeren S et al. CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses. Biomaterials40, 88 – 97 (2015).
   PubMed Web of Science ®Google Scholar
• Joshi VB Geary SM Salem AK . Biodegradable particles as vaccine delivery systems: size matters. AAPS J.15 (1), 85 – 94 (2013).
   PubMed Web of Science ®Google Scholar
• Zhao L Seth A Wibowo N et al. Nanoparticle vaccines. Vaccine32 (3), 327 – 337 (2014).
   PubMed Web of Science ®Google Scholar
• Honary S Zahir F . Effect of zeta potential on the properties of nano-drug delivery systems-a review (Part 2). Trop. J. Pharmaceut. Res.12 (2), 265 – 273 (2013).
   Google Scholar
• Thamake SI Raut SL Ranjan AP Gryczynski Z Vishwanatha JK . Surface functionalization of PLGA nanoparticles by non-covalent insertion of a homo-bifunctional spacer for active targeting in cancer therapy. Nanotechnology22 (3), 035101 (2011).
   PubMed Web of Science ®Google Scholar
• Fröhlich E . The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int. J. Nanomedicine7, 5577 (2012).
   PubMed Web of Science ®Google Scholar
• Yue Z Wei W Lv P et al. Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. Biomacromolecules12 (7), 2440 – 2446 (2011).
   PubMed Web of Science ®Google Scholar
• Ranjan AP Mukerjee A Helson L Vishwanatha JK . Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy. J. Nanobiotechnol.10 (38), 20 (2012).
   PubMedGoogle Scholar
• Melief CJ . Cancer immunotherapy by dendritic cells. Immunity29 (3), 372 – 383 (2008).
   PubMed Web of Science ®Google Scholar
• Ardavín C Amigorena S de Sousa CR . Dendritic cells: immunobiology and cancer immunotherapy. Immunity20 (1), 17 – 23 (2004).
   PubMedGoogle Scholar
• Cella M Sallusto F Lanzavecchia A . Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol.9 (1), 10 – 16 (1997).
   PubMed Web of Science ®Google Scholar
• Ikeda H Old LJ Schreiber RD . The roles of IFNγ in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev.13 (2), 95 – 109 (2002).
   PubMed Web of Science ®Google Scholar
• Schroder K Hertzog PJ Ravasi T Hume DA . Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol.75 (2), 163 – 189 (2004).
   PubMed Web of Science ®Google Scholar
• Lamagna C Aurrand-Lions M Imhof BA . Dual role of macrophages in tumor growth and angiogenesis. J. Leukoc. Biol.80 (4), 705 – 713 (2006).
   PubMed Web of Science ®Google Scholar